CAJ | 학술논문

目的总结腔内治疗锁骨下动脉局限性阻塞的经验.方法回顾性分析2004年1月至2014年12月首都医科大学附属北京朝阳医院行腔内治疗的锁骨下动脉阻塞的85例(88条)患者的临床资料.所有操作都在局麻下进行,经股动脉途径53例,肱动脉途径14例,股动脉结合肱动脉途径19例,桡动脉途径2例.共置入82个支架.术后1、3、6和12个月随诊,以后每年复查1次.结果 82条血管成功置入支架,技术成功率93.2％,6条血管技术失败.放支架前后血管狭窄率分别为(85±11)％和(4±8)％,两者差异有统计学意义(t =41.293,P=0.000).患侧/健侧肱动脉收缩压差从(44±18) mmHg降至(3±5) mmHg,两者差异有统计学意义(P=0.000).初始通畅率12个月为97.6％,24个月为92.8％,5年为83％. 结论腔内治疗近端锁骨下动脉阻塞性病变近远期疗效均较好,可作为锁骨下动脉阻塞治疗的第一选择.
목적 총결강내치료쇄골하동맥국한성조새적경험.방법 회고성분석2004년1월지2014년12월수도의과대학부속북경조양의원행강내치료적쇄골하동맥조새적85례(88조)환자적림상자료.소유조작도재국마하진행,경고동맥도경53례,굉동맥도경14례,고동맥결합굉동맥도경19례,뇨동맥도경2례.공치입82개지가.술후1、3、6화12개월수진,이후매년복사1차.결과 82조혈관성공치입지가,기술성공솔93.2％,6조혈관기술실패.방지가전후혈관협착솔분별위(85±11)％화(4±8)％,량자차이유통계학의의(t =41.293,P=0.000).환측/건측굉동맥수축압차종(44±18) mmHg강지(3±5) mmHg,량자차이유통계학의의(P=0.000).초시통창솔12개월위97.6％,24개월위92.8％,5년위83％. 결론 강내치료근단쇄골하동맥조새성병변근원기료효균교호,가작위쇄골하동맥조새치료적제일선택.
Objective Endovascular therapy is a treatment for localized occlusion of the subclavian artery.In this study the long-term experience with 85 patients was investigated.Methods Between January 2004 and December 2014,under local anesthesia we used endovascular therapy to treat 88 subclavian arterial obstructive lesions in 85 patients.The approaches included from femoral arteries (n =53),brachial arteries (n =14),radial arteries (n =2),and both femoral arteries and brachial arteries (n =19).Eighty-two stents were implanted.All patients were followed-up at 1,3,6,and 12 months postprocedure,and annually thereafter.Results Technical success (93.2％) in 82 arteries.There were six technical failures.Arterial stenosis pre-and post-stenting was (85 ± 11)％ and (4 ±8)％ (t =41.293,P =0.000).Systolic blood pressure difference between the two brachial arteries was (44 ± 18) mmHg vs (3 ± 5) mmHg (t =8.197,P=0.000).Primary patency was 97.6％ at 12 months,92.8％ at 24 mouths,and 83％ at 5 years.Conclusions Endovascular therapy for proximal subclavian arterial obstructive lesions is safe and effective.This minimally invasive treatment can be used as the first choice of treatment for subclavical arterial obstructive lesions.